Marie-Claire, C.
Lejeune, F. X.
Mundwiller, E.
Ulveling, D.
Moszer, I.
Bellivier, F.
Etain, B.
Funding for this research was provided by:
Centre National de la Recherche Scientifique
Article History
Received: 10 January 2020
Accepted: 3 July 2020
First Online: 22 July 2020
Competing interests
: F. Bellivier has received honoraria and financial compensation as an independent symposium speaker from Sanofi-Aventis, Lundbeck, AstraZeneca, Eli Lilly, Bristol-Myers Squibb and Servier. B. Etain has received honoraria form Sanofi-Aventis. All other authors have no conflicts of interest.